Relmada Therapeutics Inc (RLMD) Directors and Executive Officers - CSIMarket
CSIMarket
 
Relmada Therapeutics Inc  (NASDAQ: RLMD)

Relmada Therapeutics Inc

Officers & Directors


1. Sergio Traversa - Chief Executive Officer and Director
Sergio Traversa serves as the Chief Executive Officer and has held this position since co-founding Relmada Therapeutics in 2004. He has over 25 years of experience in the biopharmaceutical industry and has held leadership roles at various companies, including Pfizer and Hoffmann-La Roche.

2. Maged Shenouda - Chief Financial Officer
Maged Shenouda is the Chief Financial Officer and serves as the Principal Financial and Accounting Officer of Relmada Therapeutics.

3. Paul Kelly - Director
Paul Kelly is a director at Relmada Therapeutics.

4. John Glasspool - Director
John Glasspool serves as a director for Relmada Therapeutics.

5. Sergio Traversa - Chief Executive Officer, and Director
Sergio Traversa also holds the title of Director at Relmada Therapeutics.

6. Charles J. Casamento - Chairman of the Board
Charles J. Casamento serves as the Chairman of the Board of Relmada Therapeutics.

7. Fabiana Fedeli - Director
Fabiana Fedeli is a director at Relmada Therapeutics.

8. Marcum LLP
Marcum LLP has served as the auditor for the company since its establishment.

(Note: The earlier information about other executives, including Michael Becker, Li Zhou, Charles T. Leger, Shamah D. Shubert, and Mary Coleman, is not included in the new information and thus omitted.),

Relmada Therapeutics Inc currently has 17 employees.






RLMD Management Effectiveness RLMD Revenue per Employee RLMD Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.